TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Vitamin C, GW841819X
Phytochemical Name Vitamin C (PubChem CID: 54670067 )
Anticancer drug Name GW841819X (PubChem CID: / )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Decreasing Drug Toxicity
Hide/Show
Combination Pair ID: 536
Pair Name Vitamin C, GW841819X
Disease Info [ICD-11: 2C30] Melanoma Investigative
Gene Regulation Down-regulation Expression BRD4 hsa23476
Down-regulation Expression H4C12 hsa8362
Down-regulation Expression HAT1 hsa8520
Down-regulation Expression HRH4 hsa59340
In Vitro Model A2058 Amelanotic melanoma Homo sapiens (Human) CVCL_1059
SK-MEL-28 Cutaneous melanoma Homo sapiens (Human) CVCL_0526
SK-MEL-2 Melanoma Homo sapiens (Human) CVCL_0069
C8161 Cutaneous melanoma Homo sapiens (Human) CVCL_6813
1205Lu Cutaneous melanoma Homo sapiens (Human) CVCL_5239
In Vivo Model Mice were then engrafted on the neck by injecting 2×10⁵ mouse melanoma cells, B16-F10, to produce experimental tumor.
Result This study shows that ascorbate can enhance the efficacy of BET inhibitors, providing a possible clinical solution to challenges arising in phase I trials from the dose-dependent side effects of this class of epigenetic therapy.
03. Reference
No. Title Href
1 Vitamin C Sensitizes Melanoma to BET Inhibitors. Cancer Res. 2018 Jan 15;78(2):572-583. doi: 10.1158/0008-5472.CAN-17-2040. Click
It has been 48673 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP